Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesProfound Medical Corp

Profound Medical Corp

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
6.99 USD 0.26 ( 3.86%)
Last update at 2026-11-03T21:00:00Z
VOLUME
203528
Market Cap
179.55M

Momentum Score

…

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
6.66
Low
7.08
High
52 Week Price Range
7.11
Low
15.49
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
6.73
Dividend Yield
-
Revenue TTM
7.25M
Revenue Per Share
0.33
Gross Profit TTM
3.02M
Debt / Equity
0.25
ROE
-59.26%
Net Debt
-18.18M
ROCE
-79.25%
Diluted EPS TTM
-1.30

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -28.38M -30.59M -21.58M -15.31M -15.07M
Net income -28.67M -30.70M -21.62M -15.46M -15.24M
Selling general administrative 9.46M 10.31M 7.57M 5.88M 4.89M
Selling and marketing expenses 8.47M 7.65M 4.86M 2.14M 3.00M
Gross profit 3.02M 2.95M 3.47M 2.42M 0.60M
Reconciled depreciation 1.60M 1.88M 1.54M 1.54M 1.23M
Ebit -29.60M -30.29M -18.86M -15.13M -14.47M
Ebitda -25.47M -28.41M -16.63M -13.22M -13.24M
Depreciation and amortization 4.13M 1.88M 2.23M 1.91M 1.23M
Operating income -29.60M -30.29M -18.86M -15.13M -14.83M
Other operating expenses 36.28M 37.16M 26.17M 19.36M 16.74M
Interest expense 0.17M 0.30M 0.54M 0.54M 0.76M
Tax provision 0.29M 0.10M 0.04M 0.19M 0.23M
Interest income 0.80M 0.20M 0.69M 0.48M 0.48M
Net interest income 0.92M -0.31M 0.15M -0.89M -0.55M
Income tax expense 0.29M 0.10M 0.04M 0.15M 0.17M
Total revenue 6.68M 6.87M 7.30M 4.23M 1.91M
Total operating expenses 32.62M 33.24M 22.34M 17.56M 15.43M
Cost of revenue 3.66M 3.92M 3.83M 1.81M 1.31M
Total other income expense net 1.22M -0.30M -2.71M -0.18M 0.15M
Net income from continuing ops -28.67M -30.70M -21.62M -20.19M -20.76M
Net income applicable to common shares -28.67M -30.70M -21.62M -15.22M -20.76M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 43.69M 64.42M 86.78M 104.60M 29.89M
Intangible assets 0.49M 0.68M 1.44M 1.90M 2.40M
Other current assets 1.40M 1.22M 1.15M 1.07M 1.02M
Total liab 12.67M 12.42M 6.16M 7.25M 15.60M
Total stockholder equity 31.02M 52.00M 80.62M 97.35M 14.29M
Other current liab - 0.92M 0.25M 0.76M 0.53M
Common stock 216.28M 205.82M 219.58M 211.53M 99.72M
Capital stock 217.39M 205.82M 219.58M 211.53M 99.72M
Retained earnings -216.82M -189.36M -160.69M -129.99M -100.34M
Other liab - 0.76M 0.88M 1.08M 0.65M
Good will - 0.00M 2.69M 2.68M 2.61M
Other assets 0.00M - 3.62M - -
Cash 26.08M 46.52M 67.15M 83.91M 14.72M
Total current liabilities 6.33M 4.18M 4.16M 4.81M 8.18M
Current deferred revenue 0.72M 0.47M 0.48M 0.36M 0.50M
Net debt -18.18M -38.29M -65.78M -82.24M -3.81M
Short term debt 2.35M 0.76M 0.25M 0.31M 4.14M
Short long term debt 2.10M 0.52M - - 5.14M
Short long term debt total 7.90M 8.23M 1.38M 1.68M 10.91M
Other stockholder equity 19.59M 18.70M 16.99M 11.25M 14.99M
Property plant equipment - 1.72M 1.90M 2.28M 2.22M
Total current assets 41.68M 62.02M 77.12M 97.74M 22.68M
Net tangible assets - 51.32M 76.49M 92.77M 9.34M
Net receivables 7.25M 6.34M 1.41M 7.43M 3.29M
Long term debt 5.00M 6.65M - - 6.72M
Inventory 6.95M 7.94M 7.41M 5.33M 3.65M
Accounts payable 3.27M 2.03M 3.18M 3.38M 3.01M
Accumulated other comprehensive income 11.97M 16.84M 4.75M 4.57M -0.09M
Common stock total equity - - - 211.53M 130.27M
Non currrent assets other -0.00M - 3.62M - 0.00M
Non current assets total 2.00M 2.40M 9.65M 6.86M 7.21M
Capital lease obligations 0.84M 1.06M 1.38M 1.68M 2.38M
Long term debt total - - - - 8.85M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00M -0.59M -0.35M -0.25M 0.00M
Change to liabilities -0.57M -0.36M 0.28M 0.10M -0.96M
Total cashflows from investing activities - -0.59M -0.35M -0.19M -0.19M
Net borrowings 6.92M -0.39M -9.61M -1.25M 12.33M
Total cash from financing activities 7.03M 5.95M 87.43M 6.75M 27.81M
Change to operating activities -2.09M -0.01M 1.25M -1.74M 0.46M
Net income -28.67M -30.70M -21.62M -15.46M -15.24M
Change in cash -20.64M -16.76M 69.11M -8.78M 14.38M
Begin period cash flow 67.15M 83.91M 14.80M 23.49M 8.15M
End period cash flow 46.52M 67.15M 83.91M 14.72M 22.53M
Total cash from operating activities -25.80M -22.36M -20.57M -15.33M -13.43M
Issuance of capital stock - 0.00M 85.52M 8.80M 25.33M
Depreciation 1.60M 1.88M 1.54M 1.54M 1.23M
Change to inventory -1.86M -2.49M -2.14M -0.87M -1.62M
Change to account receivables -1.42M 2.00M -4.03M -1.05M 1.15M
Sale purchase of stock - - - 11.51M 34.61M
Other cashflows from financing activities 7.39M 6.33M 11.52M -0.79M 6.78M
Change to netincome 6.89M 7.34M 4.14M 2.40M 2.15M
Capital expenditures 0.00M 0.59M 0.35M 0.19M 0.03M
Change in working capital -5.63M -0.88M -4.63M -3.74M -0.99M
Stock based compensation 4.24M 7.21M 3.02M 1.28M 0.80M
Other non cash items 2.66M 0.42M 0.89M 0.91M 0.85M
Free cash flow -25.80M -22.95M -20.92M -15.53M -13.43M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PROF
Profound Medical Corp		 0.26
3.86%		 6.99 - - 27.29 6.19 24.68 -6.63
ABT
Abbott Laboratories		 -
-%		 109.40 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -0.41
0.41%		 98.88 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 3.74
1.22%		 310.55 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 0.66
1.38%		 48.35 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Profound Medical Corp

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5

647 476 1350

https://www.profoundmedical.com

131

Name Title Year Born
Dr. Arun Swarup Menawat MBA, Ph.D. Chairman & CEO 1955
Mr. Rashed Dewan Chief Financial Officer 1968
Dr. Mathieu Burtnyk Sr. VP of Product Leader TULSA-PRO 1982
Mr. Stephen Kilmer Investor Relations NA
Mr. Hartmut Warnken Chief Commercial Officer of OUS NA
Mr. Jacques F. Cornet Sr. VP & Product Leader Sonalleve 1956
Mr. Michael Mydra VP & Head of Global Market Access NA
Mr. Abbey Goodman Chief Commercial Officer of US NA
Mr. Matthew Sobczyk C.A., CPA Assistant Corp. Controller NA
Mr. Levant Tinaz Software Developer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…